Bridging Locoregional Therapy Prolongs Survival in Patients Listed for Liver Transplant with Hepatocellular Carcinoma.

about

Efficacy of loco-regional treatment for hepatocellular carcinoma prior to living donor liver transplantation: a report from a single center in Egypt.

P2860

Q55263893-CE3E3EA2-E639-4B8C-B19B-39AED57285C4

P2860

Bridging Locoregional Therapy Prolongs Survival in Patients Listed for Liver Transplant with Hepatocellular Carcinoma.

Item

http://www.wikidata.org/entity/Q40450035

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Bridging Locoregional Therapy ...... with Hepatocellular Carcinoma.

@en

type

Item

label

Bridging Locoregional Therapy ...... with Hepatocellular Carcinoma.

@en

prefLabel

Bridging Locoregional Therapy ...... with Hepatocellular Carcinoma.

@en

P1476

Bridging Locoregional Therapy ...... with Hepatocellular Carcinoma.

@en

P2093

Di Zhang

http://www.w3.org/2001/XMLSchema#string

Hyun S Kim

http://www.w3.org/2001/XMLSchema#string

James Spivey

http://www.w3.org/2001/XMLSchema#string

Minzhi Xing

http://www.w3.org/2001/XMLSchema#string

Samir Parekh

http://www.w3.org/2001/XMLSchema#string

Sonali Sakaria

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

Imaging predictors of the response to transarterial chemoembolization in patients with hepatocellular carcinoma: a radiological-pathological correlation.

Radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation.

Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation.

Lack of benefit of pre-transplant locoregional hepatic therapy for hepatocellular cancer in the current MELD era.

P2888

s00270-016-1505-0

P304

410-420

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00270-016-1505-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

S Knechtle

Renumathy Dhanasekaran

P577

2016-11-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1044185265

http://www.w3.org/2001/XMLSchema#string

P698

27900445

http://www.w3.org/2001/XMLSchema#string

Bridging Locoregional Therapy Prolongs Survival in Patients Listed for Liver Transplant with Hepatocellular Carcinoma.

about

P2860

P2860

Bridging Locoregional Therapy Prolongs Survival in Patients Listed for Liver Transplant with Hepatocellular Carcinoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698